A Study of LY3985863 in Healthy Participants

NCT07030127 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LY3985863
DRUG: Placebo

Sponsor

Eli Lilly and Company